top of page
Search


Psychedelic-Assisted Therapies Enter Addiction Treatment Conversation
Psilocybin is not FDA-approved to treat substance use disorders. The findings below come from clinical research and do not support self-administering psilocybin or other psychedelics. Any use of these substances for treatment should occur only under a healthcare provider's guidance and as part of an appropriate medical protocol. Psilocybin has recently been evaluated in clinical trials as a possible treatment for several substance use disorders, including smoking cessation an
1 hour ago


Polysubstance Use Disorders Common Among U.S. Adults
Early Substance Use Also Linked to Higher Rates of Polysubstance Use Disorders Despite slight decreases in overall overdose deaths in recent years, deaths involving multiple drugs have risen over time. A study published in Molecular Psychiatry examined the prevalence of U.S. adults who had multiple substance use disorders (SUDs)––also known as a polysubstance use disorder––and whether the age at which they first used substances was associated with the number of disorders they
Nov 5


Cannabis and Mental Health Treatment: What Does the Research Show?
Researchers conducted a review of the scientific literature to determine if using cannabis helped treat mental health problems. They identified 15 articles, divided by the type of mental health condition and form of cannabis used as a treatment. Overall, they found: No clear benefits: Evidence is too limited and uncertain to support cannabis as a treatment for conditions like post‑traumatic stress disorder, anxiety, depression, or ADHD. Some possible small benefit: A few stud
Nov 5


Does Cannabis Help or Hurt Sleep? Insights from a Long-Term Study
Many people use cannabis believing it helps them sleep. Researchers sought to understand whether cannabis (marijuana) use is linked to sleep quality in middle-aged adults. Researchers followed participants in a long-running U.S. health study for up to 35 years and examined both: Lifetime cannabis use (how much cannabis people had used over many years) Recent cannabis use (use within the past 30 days) To measure sleep, they used: A wearable device that tracked sleep objectivel
Nov 4


Alcohol Continues to Lead U.S. Treatment Admissions, Followed by Methamphetamine and Synthetic Opioids
A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a comprehensive look at substance use disorder (SUD) treatment across the United States, including who is entering treatment, what substances are most commonly involved, and what services are being utilized. Drawing on data from the Treatment Episode Data Set (TEDS), the annual report captures admissions and discharges among individuals ages 12 and older receiving treatment at
Nov 3


New Review Examines Psychosocial Treatments for Substance Use Disorder
Effective treatment for substance use disorder (SUD) can include counseling and other psychosocial approaches, such as Cognitive Behavioral Therapy (CBT) and Contingency Management (CM). These therapies can help people build coping skills, manage cravings, strengthen relationships, and work toward their own recovery goals. A systematic review published in Clinical Psychology & Psychotherapy examined 64 randomized controlled trials published between 2021 and 2025. The studies
Nov 2


Semaglutide Shows Promise as Potential New Treatment for Alcohol Use Disorder
Semaglutide, a GLP-1 receptor agonist widely used to treat obesity, has shown promise in treating Alcohol Use Disorder (AUD). Researchers in Copenhagen, Denmark, conducted a study with individuals seeking treatment for AUD who also had comorbid obesity. Participants were randomly assigned to receive either semaglutide or a placebo, alongside cognitive behavioral therapy. Those who received semaglutide achieved a 41% reduction in heavy drinking days—an outcome nearly 14% great
Nov 2


Researchers Make Progress Toward a Pain-Relieving Medication with Minimal Risk of Addiction
Developing effective pain-relieving medication with a low risk of addiction has long been a significant challenge in medical research. This year, a team of researchers at the National Institutes of Health (NIH) identified a novel, highly potent synthetic opioid compound that demonstrates substantial pain reduction without the classic hallmarks of addiction. The research team, led by scientists at the National Institute on Drug Abuse (NIDA), revisited an understudied class of
Oct 27


Brain Scans Reveal Why Stress Makes It Hard to Quit Smoking
A large body of research identifies the insula as a critical brain region involved in maintaining tobacco use disorder (TUD). The insula integrates emotion, cognition, and distress identification, linking distress awareness to cognitive control networks. Among daily smokers, distress triggers cravings and decreases the capacity to tolerate negative emotions, a key predictor of long-term cessation success. In this study, researchers investigated whether individual differences
Oct 27
bottom of page
